Simplex Trading’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $117K | Sell |
596
-4,362
| -88% | -$847K | ﹤0.01% | 4905 |
|
|
2025
Q4 | $860K | Buy |
4,958
+4,147
| +511% | +$755K | ﹤0.01% | 2775 |
|
|
2025
Q3 | $154K | Buy |
+811
| New | +$144K | ﹤0.01% | 5246 |
|
|
2025
Q2 | – | Sell |
-5,259
| Closed | -$913K | – | 8855 |
|
|
2025
Q1 | $889K | Buy |
5,259
+4,171
| +383% | +$685K | ﹤0.01% | 2808 |
|
|
2024
Q4 | $164K | Buy |
+1,088
| New | +$169K | ﹤0.01% | 4709 |
|
|
2024
Q2 | – | Sell |
-14,148
| Closed | -$1.94M | – | 8970 |
|
|
2024
Q1 | $1.88M | Buy |
+14,148
| New | +$1.84M | ﹤0.01% | 2464 |
|
|
2023
Q2 | – | Sell |
-3,271
| Closed | -$451K | – | 9150 |
|
|
2023
Q1 | $462K | Buy |
+3,271
| New | +$468K | ﹤0.01% | 3351 |
|
|
2022
Q3 | – | Sell |
-1,437
| Closed | -$189K | – | 10075 |
|
|
2022
Q2 | $191K | Sell |
1,437
-6,937
| -83% | -$945K | ﹤0.01% | 4668 |
|
|
2022
Q1 | $1.15M | Buy |
+8,374
| New | +$1.17M | ﹤0.01% | 2752 |
|
|
2021
Q3 | – | Sell |
-561
| Closed | -$82.1K | – | 9784 |
|
|
2021
Q2 | $74K | Buy |
561
+506
| +920% | +$66.3K | ﹤0.01% | 7147 |
|
|
2021
Q1 | $7K | Buy |
+55
| New | +$6.78K | ﹤0.01% | 8067 |
|
|
2020
Q3 | – | Sell |
-385
| Closed | -$45.5K | – | 7910 |
|
|
2020
Q2 | $43K | Sell |
385
-19,082
| -98% | -$2.02M | ﹤0.01% | 5627 |
|
|
2020
Q1 | $1.56M | Buy |
19,467
+3,656
| +23% | +$379K | ﹤0.01% | 1484 |
|
|
2019
Q4 | $1.69M | Buy |
15,811
+10,487
| +197% | +$1.09M | ﹤0.01% | 1627 |
|
|
2019
Q3 | $569K | Buy |
+5,324
| New | +$547K | ﹤0.01% | 2489 |
|
|
2019
Q2 | – | Sell |
-19,497
| Closed | -$1.87M | – | 7224 |
|
|
2019
Q1 | $1.75M | Buy |
19,497
+17,904
| +1,124% | +$1.55M | ﹤0.01% | 1490 |
|
|
2018
Q4 | $132K | Buy |
+1,593
| New | +$149K | ﹤0.01% | 3571 |
|
|
2018
Q3 | – | Sell |
-1,230
| Closed | -$135K | – | 7514 |
|
|
2018
Q2 | $135K | Sell |
1,230
-2,026
| -62% | -$211K | ﹤0.01% | 3939 |
|
|
2018
Q1 | $326K | Buy |
+3,256
| New | +$333K | 0.01% | 950 |
|
|
2017
Q3 | – | Sell |
-1,465
| Closed | -$156K | – | 6003 |
|
|
2017
Q2 | $162K | Buy |
+1,465
| New | +$155K | 0.01% | 1355 |
|
|
2017
Q1 | – | Sell |
-3,233
| Closed | -$308K | – | 6254 |
|
|
2016
Q4 | $297K | Buy |
+3,233
| New | +$279K | 0.02% | 805 |
|
|
2016
Q1 | – | Sell |
-198
| Closed | -$13.3K | – | 5693 |
|
|
2015
Q4 | $14K | Sell |
198
-645
| -77% | -$43.4K | ﹤0.01% | 3003 |
|
|
2015
Q3 | $51K | Buy |
+843
| New | +$58.9K | ﹤0.01% | 1977 |
|
Other funds holding DGX
VCM
VPM
EIG
Simplex Trading's DGX Position: Q1 2026 in Review
Simplex Trading reduced its Quest Diagnostics (DGX) stake by 88% in Q1 2026, selling an estimated $847K and leaving 596 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #4905.
Simplex Trading first reported a position in DGX in Q3 2015 and has held it in 23 quarters since. The position peaked at $1.88M in Q1 2024. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Simplex Trading held 596 shares of Quest Diagnostics worth $117K as of Q1 2026.
- Simplex Trading sold 4,362 Quest Diagnostics shares in Q1 2026, an estimated $847K.
- Quest Diagnostics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4905 holding.
- Simplex Trading first reported a position in Quest Diagnostics in Q3 2015 and has held it in 23 quarters since.
- Simplex Trading's Quest Diagnostics position peaked at $1.88M in Q1 2024.
- 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.